217 related articles for article (PubMed ID: 18287616)
1. Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a.
Mukherjee P; Faber AC; Shelton LM; Baek RC; Chiles TC; Seyfried TN
J Lipid Res; 2008 May; 49(5):929-38. PubMed ID: 18287616
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.
Mirkin BL; Clark SH; Zhang C
Cell Prolif; 2002 Apr; 35(2):105-15. PubMed ID: 11952645
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.
Bremer EG; Schlessinger J; Hakomori S
J Biol Chem; 1986 Feb; 261(5):2434-40. PubMed ID: 2418024
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration.
Lang Z; Guerrera M; Li R; Ladisch S
Biochem Biophys Res Commun; 2001 Apr; 282(4):1031-7. PubMed ID: 11352656
[TBL] [Abstract][Full Text] [Related]
6. Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis.
Margheri F; Papucci L; Schiavone N; D'Agostino R; Trigari S; Serratì S; Laurenzana A; Biagioni A; Luciani C; Chillà A; Andreucci E; Del Rosso T; Margheri G; Del Rosso M; Fibbi G
J Cell Mol Med; 2015 Jan; 19(1):113-23. PubMed ID: 25313007
[TBL] [Abstract][Full Text] [Related]
7. Monosialic ganglioside GM3 specifically suppresses the monocyte adhesion to endothelial cells for inflammation.
Kim SJ; Chung TW; Choi HJ; Jin UH; Ha KT; Lee YC; Kim CH
Int J Biochem Cell Biol; 2014 Jan; 46():32-8. PubMed ID: 24120649
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation.
Bremer EG; Hakomori S; Bowen-Pope DF; Raines E; Ross R
J Biol Chem; 1984 Jun; 259(11):6818-25. PubMed ID: 6327695
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
Chen HH; Zhou HJ; Wu GD; Lou XE
Pharmacology; 2004 May; 71(1):1-9. PubMed ID: 15051917
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic and angiostatic microenvironment in tumors--role of gangliosides.
Alessandri G; Cornaglia-Ferraris P; Gullino PM
Acta Oncol; 1997; 36(4):383-7. PubMed ID: 9247098
[TBL] [Abstract][Full Text] [Related]
11. Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulating epidermal growth factor receptors.
Kim SM; Jung JU; Ryu JS; Jin JW; Yang HJ; Ko K; You HK; Jung KY; Choo YK
Biochem Biophys Res Commun; 2008 Jul; 371(4):866-71. PubMed ID: 18471991
[TBL] [Abstract][Full Text] [Related]
12. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
Yeh CH; Peng HC; Yang RS; Huang TF
Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
[TBL] [Abstract][Full Text] [Related]
13. Physiological concentrations of gangliosides GM1, GM2 and GM3 differentially modify basic-fibroblast-growth-factor-induced mitogenesis and the associated signalling pathway in endothelial cells.
Slevin M; Kumar S; He X; Gaffney J
Int J Cancer; 1999 Jul; 82(3):412-23. PubMed ID: 10399959
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
15. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
16. Effects of gangliosides GM3 and De-N-acetyl GM3 on epidermal growth factor receptor kinase activity and cell growth.
Song WX; Vacca MF; Welti R; Rintoul DA
J Biol Chem; 1991 Jun; 266(16):10174-81. PubMed ID: 1645342
[TBL] [Abstract][Full Text] [Related]
17. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
18. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
Sachinidis A; Kraus R; Seul C; Meyer zu Brickwedde MK; Schulte K; Ko Y; Hoppe J; Vetter H
Eur J Cell Biol; 1996 Sep; 71(1):79-88. PubMed ID: 8884181
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside GM3 inhibits the proliferation of cultured keratinocytes.
Paller AS; Arnsmeier SL; Alvarez-Franco M; Bremer EG
J Invest Dermatol; 1993 Jun; 100(6):841-5. PubMed ID: 8496625
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
